during follow-up of 6 +/- 3 months , two subgroups were identified : 10 of 19 patients had effective long-term reduction in vt , whereas 9 of 19 patients had poor control of ventricular arrhythmia or congestive heart failure and were discontinued from the trial .
C0042514
vt
C0085612
ventricular arrhythmia